|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘 | Inzucchi Silvio E Bergenstal Richard M Buse John B Diamant Michaela Ferrannini Ele Nauck Michael Peters Anne L Tsapas Apostolos Wender Richard Matthews David R | 2012 | EN2012，，3： | 6 |
| 2 | 高血压与糖尿病:共同发展与时间轨迹研究显示文摘在人群中2型糖尿病与高血压常合并存在。许多个体糖尿病的发展特点是血浆葡萄糖值的相对快速升高。高血压的发展是否存在相似的现象仍不明确。该研究采用来自墨西哥城糖尿病研究(Mexico city diabetes study,MCDS;一个基于西班牙裔白人的糖尿病人群研究)及Framingham后代研究(Framingham offspring study,FOS;一个基于社区的非西班牙裔白人研究)的7年随访数据,分析未合并或合并糖尿病的患者高血压发展过程中的血压变化模式。 | 赵狄 练桂丽 Tsimihodimos V Gonzalez-Villalpando C Meigs JB Ferrannini E | 2018 | 中华高血压杂志2018，26，1： | 3 |
| 3 | ADA与EASD对2型糖尿病高血糖处理:治疗启动与评定的新共识方案显示文摘在不到一年时间由同一批专家代表ADA和EASD先后起草和发布了两次关于'2型糖尿病高血糖处理的共识声明'同时发表在2008年1月和12月的《Diabetes Care》和《Diabetologia》上。第一次共识声明内容主要围绕TZDs药物的安全性,本刊作了摘译转载(参阅《中国糖尿病杂志》2008年第7期)。第二次修订的共识声明,关注点为降糖药的新分级,论据及观点比较清晰,故仍摘译供读者参考。 | Nathan DM Buse JB Davidson MB Ferrannini E Holman RR Sherwin R Zinman B 钱荣立(摘译) | 2009 | 中国糖尿病杂志2009，17，1： | 2 |
| 4 | The metabolic syndrome:time for a criticaL appraisal:joint statement from the American Diabetes Association and the European Association for the Study of Diabetes 显示文摘 | Kahn R Buse J Ferrannini E | 2005 | Diabetes Care2005，28，9： | 1 |
| 5 | Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism ( SAM ) study 显示文摘 | GASTALDELLI A FERRANNINI E MIYAZAKI Y | 2004 | Diabetologia2004，47，1： | 1 |
| 6 | Insulin resistance a multifaced syndrome responsible for NDDM,obesity,hypertension,dyslip idemia,and atherosclerotic cardioras culardisease显示文摘 | Defrenzo RA Ferrannini E | 1991 | Diabetes Care1991，14，3： | 1 |
| 7 | Insulin resistance, iron, and the liver显示文摘 | Ferrannini E L E | 2000 | Lancet2000，355，： | 1 |
| 8 | Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study 显示文摘 | FERRANNINI E MASSARI M NANNIPIERI M | 2009 | Diabetologia2009，52，5： | 1 |
| 9 | Association of fasting glucagon and proinsulin concentrations with insulin resistance显示文摘 | Ferrannini E Muscelli E Natali A | 2007 | Diabetologia2007，50，11： | 1 |
| 10 | Canagliflozin,a Sodium glucose co-transporter 2 inhibitor,improves model-based indices of beta cell function in patients with type 2 diabetes显示文摘 | Polidori D Mari A Ferrannini E | 2014 | Diabetologia2014，57，5： | 1 |
| 11 | Dapagliflozinmonotherapy in type 2 diabetic patients with inadequateglycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial 显示文摘 | Ferrannini E Ramos SJ Salsali A | 2010 | Diabetes Care2010，33，10： | 1 |
| 12 | Essential hypertension: an insulin-resistant state显示文摘 | Ferrannini E Haffner SM Stern MP | 1990 | J Cardiovasc Pharmacol1990，15，5： | 1 |
| 13 | Hyperinsulinaemia:the key feature of a cardiovascular and metabolic syndrome显示文摘 | Haffner SM Mitchell BD | 1991 | Diabetologia1991，40，： | 1 |
| 14 | Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise : a randomized, double-blind, placebo-controlled, phase 3 trial 显示文摘 | Ferrannini E Ramos S J | 2010 | Diabetes Care2010，10，： | 1 |
| 15 | The metabolic syndrome for a critical appraisal:joint statement from the American Diabetes Association and the European Association for the Study of Diabetes 显示文摘 | Kahn R Buse J Ferrannini E | 2005 | Diabetes Care2005，28，9： | 1 |
| 16 | Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance显示文摘 | Ferrannini E Gastaldelli A Miyazaki Y | 2003 | Diabetologia2003，46，9： | 1 |
| 17 | Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus:problems and prospects 显示文摘 | Ferrannini E | 1998 | Endocr Rev1998，19，4： | 1 |
| 18 | Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy 显示文摘 | Ahr6n B Foley J E Ferrannini E el al | 2010 | Diabetes Care2010，33，4： | 1 |
| 19 | Long-term safety andefficacy of empagliflozin, sitagliptin, and metformin: anactive-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes 显示文摘 | Ferrannini E Berk A Hantel S | 2013 | Diabetes Care2013，36，12： | 1 |
| 20 | Regulation of hepatic glucose metabolism in humans显示文摘 | DeFronzo R A Ferrannini E | | 0，，02： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员